Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Neogen (NEOG)

Neogen Q1 revenue falls 3.6% to $209.2 million; sale gain lifts net income

Mixed Impact 3 of 5 earnings Written later

Neogen reported fiscal first-quarter 2026 revenue (quarter ended August 31, 2025) of $209.2 million, down 3.6% from a year earlier, while net income rose to $36.3 million from a net loss, driven by a non-cash gain on the sale of its Cleaners & Disinfectants business. Adjusted EBITDA fell to $35.5 million from $43.7 million, and the company reaffirmed its full-year fiscal 2026 outlook, which calls for revenue of $820 million to $840 million.

Key points

  • Revenue $209.2 million vs. $217.0 million; core revenue rose 0.3%
  • Net income $36.3 million ($0.17 per diluted share) vs. net loss of $12.6 million, helped by a $76.4 million gain on sale of business
  • Adjusted EBITDA $35.5 million, margin 17.0%, vs. $43.7 million and 20.1% a year earlier
  • Fiscal 2026 outlook reaffirmed: revenue $820 million to $840 million; Adjusted EBITDA $165 million to $175 million

The filing

CompanyNeogen (NEOG)
Form8-K, current report
Filed with the SECOct 9, 2025, 7:02 AM ET
Accession number0001193125-25-235081

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 09, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.